1. Albagli-Curiel O. Ambivalent role of BCL6 in cell survival and transformation. Oncogene. 2003; 22:507–516.
Article
2. Ohno H, Fukuhara S. Significance of rearrangement of the BCL6 gene in B-cell lymphoid neoplasms. Leuk Lymphoma. 1997; 27:53–63.
Article
3. Willis TG, Dyer MJ. The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood. 2000; 96:808–822.
Article
4. Martin-Subero JI, Gesk S, Harder L, Grote W, Siebert R. Interphase cytogenetics of hematological neoplasms under the perspective of the novel WHO classification. Anticancer Res. 2003; 23:1139–1148.
5. Vargas AC, Selinger CI, Satgunaseelan L, Cooper WA, Gupta R, Stalley P, et al. Atypical Ewing sarcoma breakpoint region 1 fluorescence in-situ hybridization signal patterns in bone and soft tissue tumours: diagnostic experience with 135 cases. Histopathology. 2016; 69:1000–1011.
6. Liew M, Rowe L, Clement PW, Miles RR, Salama ME. Validation of break-apart and fusion MYC probes using a digital fluorescence in situ hybridization capture and imaging system. J Pathol Inform. 2016; 7:20.
Article
7. Paxton CN, Rowe LR, South ST. Streamlining the OncoScan array procedure for use in a clinical laboratory. J Assoc Genet Technol. 2015; 41:61–65.